Similarly, in prostate cancer, studies have shown that genes involved in oxidative stress response, such as SOD2 (superoxide dismutase 2) and CAT (catalase), play critical roles in determining the tumor’s response to radiotherapy [92, 93]. This evidence concerns the gene SOD2 and neoplasm.